Pasternak, Björn

Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study.

Arnheim-Dahlstrom, L., Pasternak, B., Svanstrom, H., Sparen, P., & Hviid, A. (2013) · BMJ

Cervical Cancer and HPV ResearchPharmacovigilance and Adverse Drug Reactions

Cited by 279

Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism

Hviid, A., Melbye, M., & Pasternak, B. (2013) · New England Journal of Medicine

Pregnancy and Medication ImpactMaternal Mental Health During Pregnancy and Postpartum

Cited by 195

Common variants associated with general and MMR vaccine–related febrile seizures

Feenstra, B., Pasternak, B., Geller, F., Carstensen, L., Wang, T., Huang, F., Eitson, J. L., Hollegaard, M. V., Svanström, H., Vestergaard, M., et al. (2014) · Nature Genetics

Epilepsy research and treatmentGenetic Associations and Epidemiology

Cited by 152

Glucagon‐like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study

Pasternak, B., Wintzell, V., Hviid, A., Eliasson, B., Gudbjörnsdottir, S., Jonasson, C., Hveem, K., Svanström, H., Melbye, M., & Ueda, P. (2024) · BMJ

Diabetes Treatment and ManagementThyroid Cancer Diagnosis and Treatment

Cited by 125

GLP-1 Receptor Agonist Use and Risk of Suicide Death

Ueda, P., Söderling, J., Wintzell, V., Svanström, H., Pazzagli, L., Eliasson, B., Melbye, M., Hviid, A., & Pasternak, B. (2024) · JAMA Internal Medicine

Diabetes Treatment and ManagementSuicide and Self-Harm Studies

Cited by 103

Maternal Glycemic Control in Type 1 Diabetes and the Risk for Preterm Birth: A Population-Based Cohort Study

Ludvigsson, J. F., Neovius, M., Söderling, J., Gudbjörnsdottir, S., Svensson, A.-M., Franzén, S., Stephansson, O., & Pasternak, B. (2019) · Annals of Internal Medicine

Gestational Diabetes Research and ManagementDiabetes Management and Research

Cited by 75

Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study

Engström, A., Wintzell, V., Melbye, M., Svanström, H., Eliasson, B., Gudbjörnsdottir, S., Hveem, K., Jonasson, C., Hviid, A., Ueda, P., et al. (2024) · Hepatology

Diabetes Treatment and ManagementLiver Disease Diagnosis and Treatment

Cited by 54

Use of DPP4 Inhibitors and GLP-1 Receptor Agonists and Risk of Intestinal Obstruction: Scandinavian Cohort Study

Ueda, P., Wintzell, V., Melbye, M., Eliasson, B., Söderling, J., Gudbjörnsdottir, S., Hveem, K., Jonasson, C., Svanström, H., Hviid, A., et al. (2024) · Clinical Gastroenterology and Hepatology

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 34

Use of incretin-based drugs and risk of cholangiocarcinoma: Scandinavian cohort study

Ueda, P., Wintzell, V., Melbye, M., Eliasson, B., Svensson, A.-M., Franzén, S., Gudbjörnsdottir, S., Hveem, K., Jonasson, C., Svanström, H., et al. (2021) · Diabetologia

Cholangiocarcinoma and Gallbladder Cancer StudiesDiabetes Treatment and Management

Cited by 31

Treatment discontinuation among users of GLP-1 receptor agonists and SGLT2 inhibitors in a national population of individuals with type 2 diabetes

Lim, C.-E., Pasternak, B., Eliasson, B., & Ueda, P. (2025) · Diabetologia

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 27